Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that - CNBC

2/10/2024

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that  CNBCMakers of Ozempic, Mounjaro race to meet demand for weight-loss drugs  The Washington PostCatalent's Indiana filling plant in hot water with the FDA yet again  FiercePharmaEU watchdog looking into impact on drug availability from Catalent-Novo deal  ReutersNovo Catalent deal to shake up CGT space - BioProcess Insider  BioProcess Insider...

Original

Categories: Drugs | Health | Science | Space

Tags: change | cnbc | deal | drug | drugs | fda | find | hot | impact | indiana | insider | loss | meet | ozempic | race | space | washington | water

---